Floatz logo

Therapeutic Asset Ratings

3,227 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Fosphenytoin
Brain Hypoxia - Ischemia
University of North Carolina, Chapel HillP4B (56)
Fosphenytoin
Traumatic Brain Injury
University of North Carolina, Chapel HillP4B (56)
Fosphenytoin
Brain Ischemia
University of North Carolina, Chapel HillP4B (56)
Fosphenytoin
Cardiac Arrest
University of North Carolina, Chapel HillP4B (56)
Fosphenytoin
Intracerebral Hemorrhage
University of North Carolina, Chapel HillP4B (56)
GABA
Epilepsy
Sherief Abd-ElsalamP4B (56)
Gadobenate Dimeglumine
Cognitive Disorder
GuerbetP4B (56)
Henagliflozin
Type 2 Diabetes Mellitus
Xiqiao ZhouP4B (56)
Hepatitis A Virus Strain Hm175 Antigen (Formaldehyde Inactivated)
Cirrhosis Of Liver
Mahidol UniversityP4B (56)
Ibuprofen
Breast Cancer
Aga Khan UniversityP4B (56)
Imipenem
Cystic Fibrosis
Hartford HospitalP4B (56)
Indocyanine Green
Prostate Cancer
Kaiser PermanenteP4B (56)
Ioflupane
Cognitive Disorder
Mayo ClinicP4B (56)
Jinfeng Pill
Polycystic Ovary Syndrome
Peking Union Medical College HospitalP4B (56)
Jnj-54135419
Traumatic Brain Injury
Rigshospitalet, DenmarkP4B (56)
Kaftrio
Cystic Fibrosis
Hopital FochP4B (56)
Lacosamide
Traumatic Brain Injury
Wake Forest University Health SciencesP4B (56)
LEAN
Chronic Pain Syndrome
Centre Hospitalier Universitaire de NīmesP4B (56)
Lemborexant
Parkinson Disease
YangPanP4B (56)
Linagliptin
Metabolic Dysfunction-Associated Steatotic Liver Disease
Zhujiang HospitalP4B (56)
Lorlatinib
Metastatic Malignant Neoplasm In The Brain
Guangdong Association of Clinical TrialsP4B (56)
Losartan
Abdominal Obesity-Metabolic Syndrome
Chong Kun Dang PharmaceuticalP4B (56)
Lurasidone
Depressive Disorder
Massachusetts General HospitalP4B (56)
Macrogols
Rectal Carcinoma
Helsinki University Central HospitalP4B (56)
Mig-Spray
Migraine Disorder
University Hospital, Clermont-FerrandP4B (56)
Showing 2926 to 2950 of 3,227 assets
PreviousPage 118 of 130Next